APA

Andorn A. C., Haight B. R., Shinde S., Fudala P. J., Zhao Y., Heidbreder C., Learned S. M., Fox N. L., Nadipelli V. R., Hassman D. & Rutrick D. (20210113). Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis. : Journal of clinical psychopharmacology.

Chicago

Andorn Anne C, Haight Barbara R, Shinde Sunita, Fudala Paul J, Zhao Yue, Heidbreder Christian, Learned Susan M, Fox Norma Lynn, Nadipelli Vijay R, Hassman David and Rutrick Daniel. 20210113. Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis. : Journal of clinical psychopharmacology.

Harvard

Andorn A. C., Haight B. R., Shinde S., Fudala P. J., Zhao Y., Heidbreder C., Learned S. M., Fox N. L., Nadipelli V. R., Hassman D. and Rutrick D. (20210113). Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis. : Journal of clinical psychopharmacology.

MLA

Andorn Anne C, Haight Barbara R, Shinde Sunita, Fudala Paul J, Zhao Yue, Heidbreder Christian, Learned Susan M, Fox Norma Lynn, Nadipelli Vijay R, Hassman David and Rutrick Daniel. Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis. : Journal of clinical psychopharmacology. 20210113.